211 related articles for article (PubMed ID: 10037517)
1. Erbium:YAG laser resurfacing for refractory melasma.
Manaloto RM; Alster T
Dermatol Surg; 1999 Feb; 25(2):121-3. PubMed ID: 10037517
[TBL] [Abstract][Full Text] [Related]
2. Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study.
Attwa E; Khater M; Assaf M; Haleem MA
Int J Dermatol; 2015 Feb; 54(2):235-44. PubMed ID: 25266556
[TBL] [Abstract][Full Text] [Related]
3. Treatment of melasma using variable square pulse Er:YAG laser resurfacing.
Wanitphakdeedecha R; Manuskiatti W; Siriphukpong S; Chen TM
Dermatol Surg; 2009 Mar; 35(3):475-81; discussion 481-2. PubMed ID: 19250309
[TBL] [Abstract][Full Text] [Related]
4. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
5. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
Alsaad SM; Ross EV; Mishra V; Miller L
Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
[TBL] [Abstract][Full Text] [Related]
6. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma.
Abdel-Raouf Mohamed H; Ali Nasif G; Saad Abdel-Azim E; Abd El-Fatah Ahmed M
J Cosmet Dermatol; 2019 Apr; 18(2):517-523. PubMed ID: 30146730
[TBL] [Abstract][Full Text] [Related]
8. A split-face comparison of fractional erbium: YAG laser plus Kligman's formula vs. Kligman's formula monotherapy for facial melasma.
Nasimi M; Ghiasi M; Lajevardi V; Nasiri F; Shakoei S
Arch Dermatol Res; 2022 Oct; 314(8):791-797. PubMed ID: 34705101
[TBL] [Abstract][Full Text] [Related]
9. Clinical and histologic evaluation of six erbium:YAG lasers for cutaneous resurfacing.
Alster TS
Lasers Surg Med; 1999; 24(2):87-92. PubMed ID: 10100645
[TBL] [Abstract][Full Text] [Related]
10. Erbium:YAG laser resurfacing of the hands, arms, and neck.
Jimenez G; Spencer JM
Dermatol Surg; 1999 Nov; 25(11):831-4; discussion 834-5. PubMed ID: 10594593
[TBL] [Abstract][Full Text] [Related]
11. A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma.
Otb S; Shaarawy E; Sadek A; Abdallah N; Agamia N; Soliman M; Tawfik AA
J Dermatolog Treat; 2022 Feb; 33(1):555-559. PubMed ID: 32420770
[TBL] [Abstract][Full Text] [Related]
12. Laser skin resurfacing of the face with a combined CO2/Er:YAG laser.
Goldman MP; Marchell N; Fitzpatrick RE
Dermatol Surg; 2000 Feb; 26(2):102-4. PubMed ID: 10691935
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
Geddes ER; Stout AB; Friedman PM
Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Histopathologic Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
Hofbauer Parra CA; Careta MF; Valente NY; de Sanches Osório NE; Torezan LA
Dermatol Surg; 2016 Apr; 42(4):507-12. PubMed ID: 26963146
[TBL] [Abstract][Full Text] [Related]
15. A Randomized, Controlled, Split-Face Study of the Efficacy of a Picosecond Laser in the Treatment of Melasma.
Lyons AB; Moy RL; Herrmann JL
J Drugs Dermatol; 2019 Nov; 18(11):1104-1107. PubMed ID: 31741350
[TBL] [Abstract][Full Text] [Related]
16. Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports.
Polnikorn N
J Cosmet Laser Ther; 2008 Sep; 10(3):167-73. PubMed ID: 18788035
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Low Energy, Low Density, Non-Ablative Fractional 1927 nm Wavelength Laser for Facial Skin Resurfacing.
Brauer JA; Alabdulrazzaq H; Bae YS; Geronemus RG
J Drugs Dermatol; 2015 Nov; 14(11):1262-7. PubMed ID: 26580875
[TBL] [Abstract][Full Text] [Related]
18. Laser therapy in the treatment of melasma: a systematic review and meta-analysis.
Lai D; Zhou S; Cheng S; Liu H; Cui Y
Lasers Med Sci; 2022 Jun; 37(4):2099-2110. PubMed ID: 35122202
[TBL] [Abstract][Full Text] [Related]
19. Treating melasma with the 1064 nm Nd:YAG laser with a 650-microsecond pulse duration: A clinical evaluation.
Greywal T; Ortiz A
J Cosmet Dermatol; 2021 Dec; 20(12):3889-3892. PubMed ID: 34762366
[TBL] [Abstract][Full Text] [Related]
20. Combined CO2/erbium:YAG laser resurfacing of peri-oral rhytides and side-by-side comparison with carbon dioxide laser alone.
McDaniel DH; Lord J; Ash K; Newman J
Dermatol Surg; 1999 Apr; 25(4):285-93. PubMed ID: 10417584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
